Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
Wegovy, Ozempic, Zepbound, Mounjaro are all brand names for a drug formulation that mimicks the glucagon-like peptide-1 receptor agonists, which will be referred to as GLP-1
Garetosmab, activin A inhibitor antibody for muscle-preservation combination regimens in obesity Recent Highlights: In June 2026, the company announced it would present new clinical data from the Phase 2 COURAGE trial that examines the effects of trevogrumab (anti-GDF8) on lean mass in people with obesity treated with semaglutide
Micronutrient dilution and added sugars intake in U.S
Type 2 diabetes People with type 2 diabetes consistently lose less weight on GLP-1 medications than those without
In one trial extension, many people started to gain back a big part of their lost weight within a year
US$ 28.64
US$ 22.48
US$ 29.17
US$ 20.57
US$ 20.17
US$ 27.56
US$ 28.72
US$ 25.84
US$ 27.98
